Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000885590-11-000057)

Filing Details

Accession Number:: 0000885590-11-000057
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-15 18:56:28
Reporting Period:: 2011-08-11

Filing Date:: 2011-08-15
Accepted Time:: 2011-08-15 18:56:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Valeant Pharmaceuticals International Inc.	VRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1426004	Michael J. Pearson	7150 Mississauga Road Mississauga A6 L5N8M5	Chief Executive Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, No Par Value	Acquisiton	2011-08-11	155,642	$38.62	5,570,503	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This number represents the weighted average purchase price with ranges purchased from $38.51 to $38.89.
This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.